Loading company…
MitrAssist develops cardiovascular devices, including interventional heart valve and coronary treatment products.
MitrAssist develops cardiovascular devices, including interventional heart valve, coronary drug balloon, and heart failure treatment products. Founded in 2017, it is based in Shanghai, China. In September 2023, it raised approximately USD 100 million in Series C funding, co-led by 6 Dimensions Capital and Centurium Capital, with participation from Anyuan Fund, Binhu Science City, Hefei Haiheng Capital Management Co., Ltd., Hefei State-Owned Assets Holding, and Jiading Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in